<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - PREDNISOLONE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>PREDNISOLONE</h1>

        <p><a href="../drugClass/PHP34623.html">CORTICOSTEROIDS (SYSTEMIC)</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Exacerbation of chronic obstructive pulmonary disease (if increased breathlessness interferes with daily activities)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                30 mg daily for 7&#8211;14 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe croup (before transfer to hospital)</span>,
                <span class="indication">Mild croup that might cause complications (before transfer to hospital)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose child"><strong>For children </strong><br/>
                1&#8211;2 mg/kg.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Mild to moderate acute asthma (when oral corticosteroid taken for more than a few days)</span>,
                <span class="indication">Severe or life-threatening acute asthma (when oral corticosteroid taken for more than a few days)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose child"><strong>For children 1 month&#8211;11 years</strong><br/>
                2 mg/kg once daily (max. per dose 60 mg) for up to 3 days, longer if necessary.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Mild to moderate acute asthma</span>,
                <span class="indication">Severe or life-threatening acute asthma</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                40&#8211;50 mg daily for at least 5 days.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years</strong><br/>
                1&#8211;2 mg/kg once daily (max. per dose 40 mg) for up to 3 days, longer if necessary.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                40&#8211;50 mg daily for at least 5 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Local treatment of inflammation (short-term)</span>,
            </h4>
            <p class="specificity"><span class="route">To the eye</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply every 1&#8211;2 hours until controlled then reduce frequency.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply every 1&#8211;2 hours until controlled then reduce frequency.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Suppression of inflammatory and allergic disorders</span>,
            </h4>
            <p class="specificity"><span class="route">By intramuscular injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 10&#8211;20 mg daily, dose preferably taken in the morning after breakfast, can often be reduced within a few days but may need to be continued for several weeks or months; maintenance 2.5&#8211;15 mg daily, higher doses may be needed; cushingoid side-effects increasingly likely with doses above 7.5 mg daily.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                25&#8211;100 mg 1&#8211;2 times a week, as prednisolone acetate.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Suppression of inflammatory and allergic disorders (initial dose in severe disease)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially up to 60 mg daily, dose preferably taken in the morning after breakfast, can often be reduced within a few days but may need to be continued for several weeks or months.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Idiopathic thrombocytopenic purpura</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 mg/kg daily, gradually reduce dose over several weeks.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Eczematous inflammation in otitis externa</span>,
            </h4>
            <p class="specificity"><span class="route">To the ear</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 2&#8211;3 drops every 2&#8211;3 hours, frequency to be reduced when relief obtained.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply 2&#8211;3 drops every 2&#8211;3 hours, frequency to be reduced when relief obtained.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Ulcerative colitis</span>,
                <span class="indication">Crohn&#8217;s disease</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 20&#8211;40 mg daily until remission occurs, followed by reducing doses, up to 60 mg daily, may be used in some cases, doses preferably taken in the morning after breakfast.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Neuritic pain or weakness heralding rapid onset of permanent nerve damage (during reversal reactions multibacillary leprosy)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 40&#8211;60 mg daily, dose to be instituted at once.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Generalised myasthenia gravis (when given on alternate days)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 10 mg once daily on alternate days, then increased in steps of 10 mg once daily on alternate days, increased to 1&#8211;1.5 mg/kg once daily on alternate days (max. per dose 100 mg).</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Generalised myasthenia gravis in ventilated patients (when given on alternate days)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 1.5 mg/kg once daily on alternate days (max. per dose 100 mg).</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Generalised myasthenia gravis (when giving daily)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 5 mg daily, increased in steps of 5 mg daily. maintenance 60&#8211;80 mg daily, alternatively maintenance 0.75&#8211;1 mg/kg daily, ventilated patients may be started on 1.5 mg/kg (max. 100 mg) on alternate days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Ocular myasthenia</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Usual dose 10&#8211;40 mg once daily on alternate days, reduce to minimum effective dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Reduction in rate of joint destruction in moderate to severe rheumatoid arthritis of less than 2 years&#8217; duration</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                7.5 mg daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Polymyalgia rheumatica</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                10&#8211;15 mg daily until remission of disease activity; maintenance 7.5&#8211;10 mg daily, reduce gradually to maintenance dose. Many patients require treatment for at least 2 years and in some patients it may be necessary to continue long term low-dose corticosteroid treatment.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Giant cell (temporal) arteritis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                40&#8211;60 mg daily until remission of disease activity, the higher dose being used if visual symptoms occur; maintenance 7.5&#8211;10 mg daily, reduce gradually to maintenance dose. Many patients require treatment for at least 2 years and in some patients it may be necessary to continue long term low-dose corticosteroid treatment.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Polyarteritis nodosa</span>,
                <span class="indication">Polymyositis</span>,
                <span class="indication">Systemic lupus erythematosus</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 60 mg daily, then maintenance 10&#8211;15 mg daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Anorexia (symptom control in palliative care)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                15&#8211;30 mg daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Pneumocystis pneumonia in moderate to severe infections associated with HIV infection</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                50&#8211;80 mg daily for 5 days, the dose is then reduced to complete 21 days of treatment, corticosteroid treatment should ideally be started at the same time as the anti-pneumocystis therapy and certainly no later than 24&#8211;72 hours afterwards. The corticosteroid should be withdrawn before anti-pneumocystis treatment is complete.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Short-term prophylaxis of episodic cluster headache as monotherapy or in combination with verapamil during verapamil titration</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                60&#8211;100 mg once daily for 2&#8211;5 days, then reduced in steps of 10 mg every 2&#8211;3 days until prednisolone is discontinued.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Proctitis</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum using suppositories</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 metered application 1&#8211;2 times a day for 2 weeks, continued for further 2 weeks if good response, to be inserted into the rectum, 1 metered application contains 20 mg prednisolone.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                5 mg twice daily, to be inserted in to the rectum morning and night, after a bowel movement.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Distal ulcerative colitis</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum using rectal foam</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 metered application 1&#8211;2 times a day for 2 weeks, continued for further 2 weeks if good response, to be inserted into the rectum, 1 metered application contains 20 mg prednisolone.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Rectal complications of Crohn's disease</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum using suppositories</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5 mg twice daily, to be inserted in to the rectum morning and night, after a bowel movement.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Rectal and rectosigmoidal ulcerative colitis</span>,
                <span class="indication">Rectal and rectosigmoidal Crohn's disease</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum using enema</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                20 mg daily for 2&#8211;4 weeks, continued if response good, to be used at bedtime.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>As it crosses the placenta 88% of prednisolone is inactivated.</p>
            </section>
      </section>



      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>notKnown:</strong> local sensitivity reactions, adrenal suppression following prolonged use in neonates in neonates, corneal thinning, scleral thinning,
              </p>
        
        
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
              <p>Patient counselling is advised for prednisolone tablets (steroid card).</p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Prednisolone (oral) for nephrotic syndome</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome">www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome</xref>
            </p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Prednisolone for asthma</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/prednisolone-for-asthma">www.medicinesforchildren.org.uk/prednisolone-for-asthma</xref>
            </p>
            </section>
      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>When used by ear:</strong>
            avoid prolonged use
          </li>
          <li>
              <strong>With rectal use:</strong>
            systemic absorption may occur with rectal preparations
          </li>
          <li>
              <strong>With systemic use:</strong>
            Duchenne&#8217;s muscular dystrophy (possible transient rhabdomyolysis and myoglobinuria following strenuous physical activity)
          </li>
        </ul>
      </section>



      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">When used by <ph outputclass="route">eye</ph> in children</h3>
              <p>
            <i>Pred Forte</i>
            <tm tmtype="reg"/> not licensed for use in children (age range not specified by manufacturer).</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">rectal</ph> use in children</h3>
              <p>Prednisolone rectal foam not licensed for use in children (age range not specified by manufacturer).</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">When used by <ph outputclass="route">ear</ph> in children</h3>
              <p>Licensed for use in children (age range not specified by manufacturers).</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <h3 class="specificity">When used by <ph outputclass="route">eye</ph></h3>
              <p>Although multi-dose prednisolone eye drops commonly contain preservatives, preservative-free unit dose vials may be available.</p>
            </section>
      </section>









      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of PREDNISOLONE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            eye drops,
            oral suspension,
            ear drops,
            oral solution,
            enema,

            <div id="PHP76532"><a href="../medicinalForm/PHP76532.html" data-target="#PHP76532" data-action="load">Tablet</a></div>
            <div id="PHP76096"><a href="../medicinalForm/PHP76096.html" data-target="#PHP76096" data-action="load">Soluble tablet</a></div>
            <div id="PHP76156"><a href="../medicinalForm/PHP76156.html" data-target="#PHP76156" data-action="load">Gastro-resistant tablet</a></div>
            <div id="PHP76912"><a href="../medicinalForm/PHP76912.html" data-target="#PHP76912" data-action="load">Oral solution</a></div>
            <div id="PHP76393"><a href="../medicinalForm/PHP76393.html" data-target="#PHP76393" data-action="load">Suspension for injection</a></div>
            <div id="PHP76460"><a href="../medicinalForm/PHP76460.html" data-target="#PHP76460" data-action="load">Ear/eye drops solution</a></div>
            <div id="PHP76984"><a href="../medicinalForm/PHP76984.html" data-target="#PHP76984" data-action="load">Eye drops</a></div>
            <div id="PHP76317"><a href="../medicinalForm/PHP76317.html" data-target="#PHP76317" data-action="load">Foam</a></div>
            <div id="PHP76240"><a href="../medicinalForm/PHP76240.html" data-target="#PHP76240" data-action="load">Suppository</a></div>
            <div id="PHP76764"><a href="../medicinalForm/PHP76764.html" data-target="#PHP76764" data-action="load">Enema</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
